Description
In this February 2020 CJC podcast, Dr. Elizabeth Swiggum and Dr. Eileen O’Meara discuss What’s New in the CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on FMR, SGLT2 inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
CJC article: https://www.onlinecjc.ca/article/S0828-282X(19)31514-4/fulltext
Guest Twitter handle: https://twitter.com/lizswiggum